Devices & Neurotechnology
Details checkedStatus confirmedCheckedcompany

Cognixion ONE Axon-R BCI Platform

Also known as: Cognixion ONE, Axon-R, Cognixion ONE Axon-R, Cognixion non-invasive BCI

Cognixion

Primary source
Company
Cognixion
Program Type
Software/Neurotech
Modality
BCI/Neurotech
Stage
Interventional/NA
Status
Active
Target Gene
Route / Mode
Wearable EEG plus augmented-reality BCI headset and research software platform
Confidence
76%
Status Confidence
Status confirmed
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
United States, Canada, Global
Population
adult, assistive-technology, speech-communication, research, accessibility
Trial IDs
1
Mechanism

Non-invasive BCI and augmented-reality headset platform combining EEG, AI, visual stimuli, biofeedback, and neurofeedback for communication and control research.

Indications
Notes

Communication/accessibility BCI record rather than a hearing-loss product. Included because the device taxonomy needs a visible non-invasive BCI layer for speech and communication neurotechnology, while retaining Tier 3 and adjacent flags.

Evidence & Sources
4 structured sources
company
Supports: canonicalName, aliases, company, programType, modality, mechanism, status, route
Open
company
Supports: notes, allCompanies
Open
clinicaltrials
Supports: trialIds, status, populationTags
Open
company
Supports: notes
Open
Clinical Trials (1)
Data Checks
hearing-adjacent-recordnot-hearing-loss-specific-programnot-fda-regulated-device-product
Related Programs